NCT01302444View on ClinicalTrials.gov

Treprostinil Combined With Tadalafil for Pulmonary Hypertension

PHASE4TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Tadalafil

Tadalafil 40mg for 12 weeks

DRUG

Placebo

Placebo for 12 weeks

Trial Locations (9)

10003

Beth Israel Medical Center, New York

10021

Weill Cornell Medical Center, New York

14642

University of Rochester Medical Center, Rochester

22042

Inova Fairfax Hospital, Falls Church

04102

Maine Medical Center, Portland

02111

Tuft's New England Medical Center, Boston

02115

Brigham & Womens Hospital, Boston

07112

Saint Barnabas Health Care System, Newark Beth Israel Medical Center, Newark

02903

Rhode Island Hospital, Providence

Sponsors

Collaborators (1)

United Therapeutics
All Listed Sponsors
collaborator

United Therapeutics

INDUSTRY

lead

Rhode Island Hospital

OTHER